Waters Corporation (WAT) Price Target Raised to $202.00 at Bank of America Corporation

Waters Corporation (NYSE:WAT) had its price target increased by Bank of America Corporation from $192.00 to $202.00 in a report published on Friday. The firm currently has a neutral rating on the medical instruments supplier’s stock.

Several other equities research analysts also recently weighed in on WAT. Zacks Investment Research raised Waters Corporation from a hold rating to a buy rating and set a $202.00 price objective for the company in a report on Thursday, July 13th. Wells Fargo & Company reaffirmed an outperform rating and set a $205.00 price target (up from $195.00) on shares of Waters Corporation in a report on Thursday, July 13th. Jefferies Group LLC reaffirmed a hold rating and set a $170.00 price target on shares of Waters Corporation in a report on Friday, July 14th. Cowen and Company reaffirmed a hold rating and set a $190.00 price target on shares of Waters Corporation in a report on Friday, July 14th. Finally, Morgan Stanley reaffirmed an underweight rating and set a $183.00 price target (up from $174.00) on shares of Waters Corporation in a report on Wednesday, July 26th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of Hold and an average target price of $193.62.

Shares of Waters Corporation (NYSE WAT) traded down $1.76 during trading on Friday, reaching $193.21. 383,100 shares of the company’s stock traded hands, compared to its average volume of 523,562. The stock has a market capitalization of $15,506.55, a price-to-earnings ratio of 27.08, a P/E/G ratio of 2.83 and a beta of 0.83. Waters Corporation has a one year low of $133.35 and a one year high of $199.78. The company has a debt-to-equity ratio of 0.66, a current ratio of 6.16 and a quick ratio of 1.90.

Waters Corporation (NYSE:WAT) last announced its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.03. The company had revenue of $565.58 million for the quarter, compared to analyst estimates of $555.25 million. Waters Corporation had a net margin of 24.34% and a return on equity of 23.61%. The firm’s revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.57 earnings per share. sell-side analysts predict that Waters Corporation will post 7.42 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Waters Corporation (WAT) Price Target Raised to $202.00 at Bank of America Corporation” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.dispatchtribunal.com/2017/11/11/waters-corporation-wat-price-target-raised-to-202-00-at-bank-of-america-corporation.html.

In related news, SVP Elizabeth B. Rae sold 12,000 shares of Waters Corporation stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $197.95, for a total transaction of $2,375,400.00. Following the completion of the sale, the senior vice president now owns 18,129 shares in the company, valued at approximately $3,588,635.55. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Rohit Khanna sold 26,913 shares of Waters Corporation stock in a transaction dated Friday, October 27th. The stock was sold at an average price of $197.93, for a total value of $5,326,890.09. Following the sale, the senior vice president now owns 13,677 shares of the company’s stock, valued at approximately $2,707,088.61. The disclosure for this sale can be found here. In the last quarter, insiders have sold 57,313 shares of company stock valued at $11,120,642. 5.07% of the stock is currently owned by company insiders.

A number of institutional investors have recently bought and sold shares of WAT. Janus Henderson Group PLC increased its position in Waters Corporation by 20,670.6% during the 2nd quarter. Janus Henderson Group PLC now owns 1,929,793 shares of the medical instruments supplier’s stock worth $354,773,000 after purchasing an additional 1,920,502 shares in the last quarter. Koch Industries Inc. boosted its stake in Waters Corporation by 36,932.0% in the 2nd quarter. Koch Industries Inc. now owns 534,742 shares of the medical instruments supplier’s stock worth $532,000 after buying an additional 533,298 shares during the last quarter. Fundsmith LLP boosted its stake in Waters Corporation by 11.7% in the 2nd quarter. Fundsmith LLP now owns 3,833,955 shares of the medical instruments supplier’s stock worth $704,834,000 after buying an additional 401,420 shares during the last quarter. Renaissance Technologies LLC boosted its stake in Waters Corporation by 214.5% in the 2nd quarter. Renaissance Technologies LLC now owns 526,400 shares of the medical instruments supplier’s stock worth $96,773,000 after buying an additional 359,000 shares during the last quarter. Finally, American Century Companies Inc. boosted its stake in Waters Corporation by 200.4% in the 3rd quarter. American Century Companies Inc. now owns 512,899 shares of the medical instruments supplier’s stock worth $92,076,000 after buying an additional 342,134 shares during the last quarter. Hedge funds and other institutional investors own 91.27% of the company’s stock.

Waters Corporation Company Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Analyst Recommendations for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply